Come by our booth to get an update on our Calprotectin,Therapeutic Drug Monitoring, Chemistry, Neuroimmunology, and Cellular Allergy portfolios
Calprotectin and TDM:
IBDoc®, the ONLY in-vitro diagnostic POC and home testing device to measure the inflammatory marker, fecal calprotectin
Health Canada License: 98903, Device class: 3 US: Not available for Sale in the US.
Quantum Blue® platform offering rapid and quantitative results for fecal calprotectin, serum calprotectin, CRP and serum infliximab trough levels (Additional trough level assays coming soon!)
Health Canada Licenses: Quantum Blue® fCAL: 83477, Quantum Blue® fCAL extended: 100161 US: Research Use Only. Not for use in diagnostic procedures in the US
BÜHLMANN fCAL® ELISA, accurate, precise, efficient calprotectin testing
Health Canada License: 80726 US: BÜHLMANN fCAL® ELISA is FDA 510(k) cleared. For in vitro Diagnostic Use.
BÜHLMANN fCAL® turbo, the new high throughput, random access fecal calprotectin assay – unique in speed, quality, flexibility
Health Canada License: 96808 US: Research Use Only. Not for use in diagnostic procedures in the US
CALEX® Cap for rapid, clean, consistent and safe stool extraction
Health Canada License: 98839 US: Research Use Only. Not for use in diagnostic procedures in the US
We offer a selection of unique, high-quality assays for Cellular Allergy testing such as the BÜHLMANN Flow CAST® product group and numerous Allergens for Basophil Activation Testing and Neuroimmunology testing such as the BÜHLMANN GanglioCombi™ products; the only screening ELISAs for anti-Ganglioside testing and Anti-MAG Autoantibodies ELISA. Other areas of BÜHLMANN’s focus include specialized niche products for Clinical Chemistry (ACE, GHB, etc.) as well as the first- to-market Chronobiology melatonin line of assays.